BackMEDIROM Healthcare Technologies Overview

MEDIROM Healthcare Technologies Operating Income

Latest operating income for MRM: $47M.

Get informed when a big investor buys or sells

+ Follow

Quarterly Operating Income

$70.63M
88.58% YoY

As of Dec 31, 2025

Annual Operating Income (TTM)

$46.88M
2128.31% YoY

Trailing 12 months ending Dec 31, 2025

Average Operating Income (Comparison Companies)

Operating Income History

Operating Income Comparison

Annual Operating Income Growth Rate (%)

Annual Operating Income Growth (Absolute)

MEDIROM Healthcare Technologies (MRM) FAQ

MEDIROM Healthcare Technologies's operating income stands at $47M as of December 2025. That compares with $-2.3M in the prior-year period — up 2128.3% year over year. Stockcircle updates this page with the newest filings so you can track how the metric evolves quarter by quarter.

MEDIROM Healthcare Technologies reported $47M in operating income versus $-2.3M a year earlier — a 2128.3% year-over-year increase. The historical chart on this page makes it easier to see whether that move is part of a longer pattern.

That compares with $-2.3M in the prior-year period — up 2128.3% year over year. Sustained growth in operating income can support a stronger franchise, while sharp declines may reflect divestitures, weaker demand, or accounting changes. Always read YoY moves with the footnotes of recent filings in mind.

The history chart shows how MEDIROM Healthcare Technologies's operating income evolved across reporting periods, while the comparison chart places MRM next to similar companies. Use both: a rising metric that still lags peers tells a different story than a rising metric that already leads the group. Growth charts, when available, highlight acceleration or slowdown.

Yes — within Consumer Discretionary, operating income is commonly used to spot outliers. MEDIROM Healthcare Technologies's reading of $47M is a starting point; confirm whether differences come from growth, margins, accounting choices, or one-time items before treating an outlier as a buy or sell signal.